Cboe reported a dip in its monthly trading volumes as the operator recorded $700 billion trading volume in the first month of 2021, a $19 billion drop from December 2020. The operator reported a second consecutive monthly slump.
According to the official numbers posted by the Cboe, January 2021 saw a total of 20 trading days with an average daily volume (ADV) of $35 billion. Despite a dip in the monthly volumes, the ADV posted a strong jump last month, compared to $32 billion in December 2020.
Cboe posted record monthly volumes in March 2020 after the coronavirus pandemic and global lockdowns accelerated interest in financial trading across the world. In March last year, Cboe reported $1.2 trillion in monthly trading volumes along with the ADV of $54.9 billion.
The operator has seen an overall growth for the last year amid increased market volatility. Apart from August 2020, the ADV remained above $29 billion for the whole year.
The latest numbers show a mixed picture for the Cboe. Despite a rise in the ADV compared to the same period a year ago, the monthly volumes slipped from $739 billion in January 2020 to $700 billion in the last month. In November 2020, Cboe reported $789 billion in monthly trading volumes. In fact, December saw a figure of $719 billion. As far as the ADVs are concerned, after a dip in December 2020, the average daily volumes are up again in January 2021.
Headquartered in Chicago, Cboe offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, US, Canadian and European equities, exchange-traded products (ETPs), global foreign exchange (FX), and volatility products based on the Cboe Volatility Index (VIX Index), recognized as the world’s premier gauge of US equity market volatility. Cboe has global offices across the Americas, Europe, and Asia, including main hubs in New York, London, Kansas City and Amsterdam. Cboe’s subsidiaries include the largest options exchange and the third-largest stock exchange operator in the US.
(Photo: Jiefei Liu/MEDILL)